Where does Cytiva BioProcess R&D AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cytiva BioProcess R&D AB ranks #6,639 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cytiva BioProcess R&D AB hold?

Cytiva BioProcess R&D AB holds 50 US utility patents granted between 2020 and 2025, spanning 17 technology areas.

What is Cytiva BioProcess R&D AB's Innovation Score?

Cytiva BioProcess R&D AB has an Innovation Score of 49.0 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cytiva BioProcess R&D AB focus on?

Cytiva BioProcess R&D AB's top technology area is B01D (Separation) with 38 patents, ranking #116 of 3,536 assignees active in that subclass. Grants appear in 17 CPC subclasses total.

Is Cytiva BioProcess R&D AB's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Cytiva BioProcess R&D AB.

What does claim depth mean for Cytiva BioProcess R&D AB's patents?

Cytiva BioProcess R&D AB's patents average 19.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cytiva BioProcess R&D AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cytiva BioProcess R&D AB

USPTO PatentsView assignee record - 50 granted patents across 17 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01D (Separation).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cytiva ranks #6,639 of 49,997 tracked US assignees by granted-patent volume, with 50 patents across 17 technology areas.

#6,639
of 49,997 US assignees by volume: Top 16%
by Innovation Score (49.0/100): 19.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R6639 · Foreign Corporation #6,639 · 50 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 50 grants
UPPER-Q #6,639/49,997
PHOTO-FINISH Capstan Systems
CPC-FOCUS B01D · 17 areas
INNOV-PAR 49.0/100
CLAIMS-RICH 19.3 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Capstan Ag Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cytiva’s 49.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.6 pts (28%) Velocity 9.3 pts (19%) Breadth 14.6 pts (30%) Claim depth 11.6 pts (24%)

Qualcomm Incorporated · highest

85
Classiq · near

49
Cytiva BioProcess… · this assignee

49
Korea Basic Science… · near

49
Sennco Solutions · near

49
SIG Technology · near

49
3D Lighting… · lowest

7

What this shows Cytiva's Innovation Score is 49.0/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cytiva?

Each dot is one of Cytiva’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cytiva’s own 19.3 claims/patent is ABOVE the 15.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cytiva vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cytiva's grants concentrate

Cytiva BioProcess R&D AB is a focused PatentsView assignee: 17 CPC subclasses with 76% of grants classified under B01D (Separation). Peak complete grant year is 2021 (15 grants) versus a trough of 3 in 2020. By volume, Cytiva sits between Capstan Ag Systems, Inc. and Dyne Therapeutics, Inc..

Cytiva's three-year grant acceleration

Cytiva BioProcess R&D AB shows 25 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Capstan Systems

50
Cascade

50
Coinplug

50
Crucible Intellec…

50
Daiki

50
Dana Motion Syste…

50
Damaka

50
Dyne Therapeutics

50
Cytiva Bioprocess… ◀

50

What this shows Cytiva holds 50 patents at rank #6,639, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cytiva

By rank, the assignees closest to #6,639 in granted patent volume.

Leaders in B01D (Separation)

Other assignees with the most granted patents in Cytiva's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cytiva, neither rank-band nor same-CPC leaders (those blocks stay above). In B01D (Separation), Cytiva ranks #116 of 3,536 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Korea Basic Science Institute 49 SIG Technology AG 49 Sennco Solutions Inc. 49 Classiq Technologies Ltd. 49

Similar claim depth

Nearest assignees by average claims per patent (19.3 here).

Carlisle Fluid Technologies, LLC 19.3 avg ThoughtSpot, Inc. 19.3 avg Interrad Medical, Inc. 19.3 avg The Travelers Indemnity Company 19.3 avg

Cytiva's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Cytiva BioProcess R&D AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	3	6.0%
2021	15	30.0%
2022	7	14.0%
2023	11	22.0%
2024	7	14.0%
2025partial year	7	14.0%

Which technologies does Cytiva BioProcess R&D AB patent most?

B01D - Separation 38

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 33

C07K - Peptides 30

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 13

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

Y10T - Technical Subjects Covered BY Former US Classification 6

C08L - Compositions OF Macromolecular Compounds 5

C08B - POLYSACCHARIDES; Derivatives Thereof 4

F16L - PIPES; Joints OR Fittings FOR PIPES; Supports FOR Pipes, Cables OR Protective TUBING; Means FOR Thermal Insulation IN General 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C12Y - Enzymes 2

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 1

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 1

Top 15 of 17 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cytiva BioProcess R&D AB's patent record in context - here's where to go next.

Cytiva BioProcess R&D AB's lead technology class is B01D (Separation), 76% of its portfolio - see every assignee active in that class. Explore B01D
Ranked #6,639 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cytiva BioProcess R&D AB against Capstan Ag Systems, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.